Cancer Center– A Cancer Center Designated by
the National Cancer Institute

Clinical Trials in the Category "Ovarian Neoplasms"

Drug Intervention Trials that are Recruiting

Study Title
 Principal Investigator Disease Category
Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites Jonathan S. Berek MD, MMS
 Ovarian Cancer
Ascites
Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors Dr. Neyssa Marina
 Ovarian Cancer
Neoplasms, Germ Cell and Embryonal
A Study of Carboplatin and Gemcitabine Plus Bevacizumab in Patients With Ovary, Peritoneal, or Fallopian Tube Carcinoma (OCEANS) Jonathan S. Berek MD, MMS
 Ovarian Cancer
AZD6244 in Treating Woman With Recurrent Low-Grade Ovarian Cancer Amreen Husain
 Ovarian Cancer
Carboplatin and Paclitaxel With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Amreen Husain
 Ovarian Cancer
Fallopian Tube Neoplasms
Peritoneal Neoplasms
Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both Ovaries Amreen Husain
 Ovarian Cancer
Osteoporosis
Breast Cancer
Combination Study Of SB-485232 (Interleukin 18) And Doxil For Advanced Stage Epithelial Ovarian Cancer Jonathan S. Berek MD, MMS
 Ovarian Cancer


Other Trials that are Recruiting

Study Title
 Principal Investigator Disease Category
Collecting Tumor Samples From Patients With Gynecological Tumors Amreen Husain
 Ovarian Cancer

Trials not Recruiting

Study Title
 Principal Investigator Disease Category
Second-Line Therapy Study For Potentially Platinum-Sensitive Relapsed Ovarian Cancer
(No longer recruiting) 		Amreen Husain
 Ovarian Cancer
Safety and Efficacy Clinical Study of SNS-595 in Patients With Platinum-Resistant Ovarian Cancer
(No longer recruiting) 		Amreen Husain
 Ovarian Cancer
Efficacy Multicentre Trial of ImmunoTherapy Vaccination With Abagovomab to Treat Ovarian Cancer Patients (MIMOSA)
(No longer recruiting) 		Jonathan S. Berek MD, MMS
 Ovarian Cancer
Safety and Efficacy Study of the Trifunctional Antibody Catumaxomab to Treat Ovarian Cancer in Women After a Complete Response to Chemotherapy
(Completed) 		Jonathan S. Berek MD, MMS
 Ovarian Cancer
Clinical Trial for Ovarian Cancer (OvaRex®)
(Terminated) 		Nelson N Teng
 Ovarian Cancer


The physicians of the Stanford Cancer Center are engaged in more than 250 clinical trials.  Contracts with some of our clinical trial sponsors prevent us from listing specific trial information on our web site. Please contact the Stanford Cancer Clinical Trials Office at 650-498-7061 for information about additional open clinical trials.

Stanford Medicine Resources:

Footer Links: